MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and ...

The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.

Novo Nordisk (NVO) said Wednesday that it launched a direct-to-patient online pharmacy through which it will offer its weight loss injection at more than half the list price. The company's NovoCare ...

Today, like so many users of the weight-loss drugs Ozempic, Mounjaro and Wegovy, I simply can't stomach the idea of alcohol.

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

By now we have all heard about Semaglutide (Ozempic) and Tirzepatide (Mounjaro).  Whether you have used it yourself or know of someone who has, we know how effective ...

Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...